GAMMA Investing’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
HWAM
CMF
MAM
LTAS
PFSRSONJ
VCM
ATC
FFA
SS
MSG
GAMMA Investing's FLGT Position: Q2 2026 in Review
GAMMA Investing reduced its Fulgent Genetics (FLGT) stake by 64% in Q2 2026, selling an estimated $18.3K and leaving 603 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3099.
GAMMA Investing first reported a position in FLGT in Q4 2023 and has held it in 11 quarters since. The position peaked at $121K in Q4 2025. 19 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.
- GAMMA Investing held 603 shares of Fulgent Genetics worth $12.4K as of Q2 2026.
- GAMMA Investing sold 1,080 Fulgent Genetics shares in Q2 2026, an estimated $18.3K.
- Fulgent Genetics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3099 holding.
- GAMMA Investing first reported a position in Fulgent Genetics in Q4 2023 and has held it in 11 quarters since.
- GAMMA Investing's Fulgent Genetics position peaked at $121K in Q4 2025.
- 19 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.
Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.